News & Stories
Contact Us
A DAT knowledge-sharing community
Explore Digital Adherence Technologies (DATs) and their impact on TB treatment adherence through our collaborative Learning Hub. Join a global community driving innovation in TB treatment adherence and access valuable insights to advance the #EndTB goal.
Smart Dispensers: the role of STAMP in TB Treatment
Discover how STAMP empowers individuals with TB to take control of their treatment journey, providing valuable insights for healthcare workers. Join the journey of technological advancements in TB care and consider STAMP as a viable option for person-centered adherence, information access, and monitoring and evaluation strategies. Learn more about STAMP today.
The Global DAT Task Force, Learning Hub Launch
The Global DAT Task Force launches its Learning Hub! Join us in this collaborative initiative and be a part of our TB care experts and digital innovators community. Together, we can drive transformative learning in the world of Digital Adherence Technologies (DATs) and shape the future of TB care.
Presentations on DATs at The Union Conference 2023
Presentations on DATs at The Union Conference 2023At The Union Conference, which will be hosted in...
Technical Brief: 5 Country Experiences with Digital Adherence Technologies
Based on the experience of implementing digital adherence technologies at scale in five different contexts, this technical brief serves to
highlight and summarize the ASCENT project implementation experiences with 3 technologies.
Budgeting for Digital Adherence Technologies in preparation for Global Fund applications
In preparation for Global Fund 2023-2025 submissions the Global DAT Task Force secretariat hosted a webinar to provide guidance on developing a budget for digital adherence technology implementation in national TB programs.
Adherence Support with BPaL(M) Roll-Out
Digital adherence technologies (DATs) are an important support tool to include in country planning for the programmatic B-PaL(M) roll out.
The smart pill box, in particular, offers a person-centric way to support adherence and retain people on treatment.
Digital Adherence Technology Presentations at The Union Conference 2022
At the Union Conference, which will be hosted virtually this year from 8-11 November 2022, there will be multiple presentations on the use of digital adherence technologies as a support tool in TB treatment.
Regional DAT workshop for Eastern Europe and Central Asia
In September 2022 the Global DAT Task Force facilitated a peer-to-peer workshop in the Eastern Europe and Central Asia region in collaboration with the Center for Health Policies and Studies (PAS Center) in Moldova.
Considerations for the inclusion of DATs in the Global Fund Covid-19 Response Mechanism Reinvestment
The Global DAT Task Force secretariat has created a document on considerations for the inclusion of Digital Adherence Technologies, as a tool to support tuberculosis treatment alongside other requests linked to the identified C19RM reinvestment priorities.
Moldova’s Implementation of VST
The TB stakeholders developed an asynchronous video-supported treatment (VST) electronic system and model of care as an additional adherence tool for people with TB who report difficulties with DOT.
Digital Adherence Technologies in the WHO Guidelines
The World Health Organization published their updated consolidated guidelines on Tuberculosis for treatment in July 2022.
As a part of the guidelines there were multiple references to the use of digital adherence technologies as a tool in TB treatment.
Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in Uganda
Digital adherence technologies like 99DOTS are increasingly considered as an alternative to directly observed
therapy for tuberculosis (TB) treatment supervision. We evaluated the cost and cost-effectiveness of 99DOTS in a high-TB burden setting.
Eswatini’s experience with Digital Adherence Technologies
At the DAT workshop in South Africa, eSwatini presented on their experience implementing digital adherence technologies – specifically video supported treatment.
Ethiopia’s experience with Digital Adherence Technologies
Ethiopia's experience with Digital Adherence TechnologiesThe Global DAT Task Force Secretariate,...
DAT Symposium in South Africa
Global DAT Task Force Symposium in Pretoria, South AfricaThe Global DAT Task Force Secretariate,...
Training Opportunity: Novel Technologies for Tuberculosis Medication Adherence Monitoring
Training Opportunity: Novel Technologies for Tuberculosis Medication Adherence Monitoring Why is...
Maia’s Story about VOT by the Global Fund
The Global Fund, in collaboration with governments and other partners, are working towards improved treatment of TB for patients like Maia. As a part of working towards this goal in Georgia, Video Observed Treatment has been implemented. Maia is using the AdhereTB app as a tool to support the DR-TB treatment, which allows her to record and upload a video of her daily medication intake at a time that suits her, thereby saving her time and transportation costs.
“99DOTS Digital Technology helped me get cured of TB.”
“I felt relieved when nurse Anton mentioned that I didn’t have to visit the clinic every day for him to see if I took my medicine. A visit every two weeks for drug refill was all that he asked of me. This meant I saved on transportation money.”
Alex: “I really like the system”
Alex* (35 years), a miner and TB patient, was enrolled on the 99DOTS system. Since the start of his treatment, he takes his medication daily. When interviewed on his experience with 99DOTS.
Riziki: “I encourage any TB patient to use 99DOTS if they can”
The 99DOTS system has helped me a lot completing the treatment this successfully.” These are comments from Riziki William (29 years), who is now back to his normal activities in the mines.
Tuberculosis patient about smart pillbox: “It’s like having a private doctor!”
Mehamed is a father of one daughter, husband and merchant of used clothes. He lives in Addis Ababa (Ethiopia) and was diagnosed with tuberculosis (TB) at the age of 27. Shortly after his diagnosis, he started his treatment supported by a smart pillbox.
Devex interview about digital adherence technologies: ‘We hope that our research will contribute to the WHO policy.”
The ASCENT project launched a global study on digital adherence technologies. Devex interviewed Kristian van Kalmthout, digital health consultant at KNCV Tuberculosis Foundation and project director at ASCENT, about the launch of the research phase.
ASCENT Ethiopia conducted an orientation meeting for civil society organization members
ASCENT in Ethiopia conducted an orientation meeting on digital adherence technologies (DAT) for two civil society organization (CSO) members to ensure community engagement activities. By engaging CSOs, ASCENT Ethiopia intents to better understand the acceptance of DATs in country context, provide insight for continuous refinement of the intervention, establish fora for discussion, dissemination of results and to advocate for the adoption of the technologies by country programs and funders.
ASCENT South Africa initiates TB community outreach activities
ASCENT South Africa recently held a campaign in the busy Tshwane’s inner city “Marabastad”, aimed at tuberculosis (TB) case finding and community education on the use of digital adherence technologies (DATs) to improve TB treatment outcomes.
Establishing a global market for digital adherence technologies
While the market for DATs is well-established in many high-income countries, relatively little is known about the size and composition of the market for these products, or even which products might be best suited to the diseases and demographics, found in low- and middle-income (LMIC) geographies.